BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22816140)

  • 1. Interview with John Patton.
    Patton JS
    Ther Deliv; 2010 Sep; 1(3):375-81. PubMed ID: 22816140
    [No Abstract]   [Full Text] [Related]  

  • 2. Professor Jan Feijen: a pioneer in biomedical polymers and controlled drug release.
    Zhong Z
    J Control Release; 2015 May; 205():3-6. PubMed ID: 26042240
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanomedicines for delivery of therapeutic proteins and biopharmaceuticals.
    Sarmento B
    Ther Deliv; 2010 Aug; 1(2):231-5. PubMed ID: 22816130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmaceutical sciences in America, 1952-2002.
    Feldmann EG
    J Am Pharm Assoc (Wash); 2002; 42(6):828-30. PubMed ID: 12482004
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug delivery: a Canadian perspective. 25 years of innovative drug delivery research.
    Burt H; Leroux JC; Amsden B; Uludag H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):iii. PubMed ID: 17280822
    [No Abstract]   [Full Text] [Related]  

  • 6. Professor Valentino J. Stella: scientist, mentor, entrepreneur, family man, and giant in pharmaceutical chemistry.
    Oliyai R; Brewster ME; Ozeki T; Rajewski RA; Charman W
    J Pharm Sci; 2012 Sep; 101(9):2989-95. PubMed ID: 22648793
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
    Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
    Int J Pharm; 2007 Mar; 332(1-2):1-16. PubMed ID: 17222523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalative nanomedicine--opportunities and challenges.
    Bur M; Henning A; Hein S; Schneider M; Lehr CM
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():137-43. PubMed ID: 19558246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pfizer-Pharmacia: the smart fit for the future.
    Wiggins WP
    Expert Opin Investig Drugs; 2003 Jan; 12(1):1-3. PubMed ID: 12517249
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine adjuvants: insights from industry. Interview by Jenaid Rees.
    Andréasson S
    Expert Rev Vaccines; 2013 Jul; 12(7):731-2. PubMed ID: 23885818
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmaceutical industry and the veterinary profession: 100 years of symbiosis.
    Brander GC
    Vet Rec; 1982 Sep; 111(12):255-8. PubMed ID: 6755874
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges for the pharmaceutical technical development of protein coformulations.
    Mueller C; Altenburger U; Mohl S
    J Pharm Pharmacol; 2018 May; 70(5):666-674. PubMed ID: 28470967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology and therapeutic delivery: a drug regulation perspective.
    Sadrieh N; Tyner KM
    Ther Deliv; 2010 Jul; 1(1):83-9. PubMed ID: 22816122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.
    Watson CJ; Whitledge JD; Siani AM; Burns MM
    J Med Toxicol; 2021 Apr; 17(2):197-217. PubMed ID: 33140232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 17. Discussing Tomorrow's Regulatory Risks Today.
    Junker B
    PDA J Pharm Sci Technol; 2017 Jan; 71(1):1. PubMed ID: 28174257
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibacterial discovery and development--the failure of success?
    Fernandes P
    Nat Biotechnol; 2006 Dec; 24(12):1497-503. PubMed ID: 17160049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Engineering for Biotherapeutics--IBC's second annual conference. Developing and improving next generation biotherapeutics.
    Smider V
    IDrugs; 2007 Mar; 10(3):176-7. PubMed ID: 17351870
    [No Abstract]   [Full Text] [Related]  

  • 20. Fifty years of pharmaceutical development.
    Boden IM
    Practitioner; 1980 May; 224(1343):513-5. PubMed ID: 6999481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.